Quibim

Quibim

Medical Imaging & Radiology

About Quibim

Quibim is a medical imaging AI company that transforms complex imaging data into actionable clinical predictions. The company has built a comprehensive cloud-based platform that extracts key radiomics drivers from large-scale imaging data registries to support drug development, clinical research, and patient care. Quibim's technology portfolio includes QP-Insights®, a platform for managing, harmonizing, and analyzing multi-omics and imaging data, alongside specialized medical device software products for specific clinical applications. Their QP-Prostate® solution streamlines prostate MRI interpretation with PI-RADS compliance, while QP-Brain® provides volumetric analysis and white matter hyperintensity assessment. QP-Liver® quantifies fat and iron concentration for comprehensive liver disease evaluation, and QP-Breast® and QP-Lung® address additional clinical needs. The company serves three primary markets: Life Sciences partnerships with biopharma companies for drug development acceleration, healthcare providers seeking clinical decision support tools, and research institutions conducting imaging biomarker discovery. Quibim's platform processes data from over 100,000 de-identified cancer patients and manages millions of research imaging studies across sites worldwide. Built on Microsoft Azure with ISO 27001:2022 certification, the platform ensures HIPAA and GDPR compliance with encryption during storage, transfer, and at file-level. Quibim's mission centers on pioneering value-based, evidence-driven solutions that identify clinical trial candidates, predict treatment response, and monitor adverse events through advanced AI models.

Clinical Focus

Medical conditions and clinical areas addressed by Quibim.

Prostate cancerBrain disordersLiver disease (steatosis, iron overload)Breast cancerLung diseaseB-Cell lymphomaNeuroblastoma

Who It Serves

Biopharma companiesHealthcare providersResearch institutionsClinical trial sites

Milestones & Awards

Recent Milestones

QP-Prostate® received Health Canada Licence (June 2024); Selected by New York for strategic AI program (May 2024); Partnership with Vara for breast cancer screening in Spain (April 2024)

Awards & Recognition

Selected as only healthtech for New York's strategic AI program; mentions Grants & Awards section on website

Key Partnerships

Vara (Germany) for breast cancer screening AI in SpainNew York strategic AI program participant

Social & Media

Company Details

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

ISO 27001:2022HIPAAGDPR

Official Sources

Last updated Jul 1, 2026

Similar Companies in this Market

View all 189
A2z Radiology Ai

A2z Radiology Ai

AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.

Adas3D Medical S.L

Adas3D Medical S.L

11-50 employees

Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.

AEYE Health

AEYE Health

11-50 employees

AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.

Agfa HealthCare N.V.

Agfa HealthCare N.V.

AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.

AI4MedImaging Medical Solutions

AI4MedImaging Medical Solutions

AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.

Aidence

Aidence

Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.

Aidoc

Aidoc

growth · 350 employees

Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.

Aikenist Technologies Pvt Ltd

Aikenist Technologies Pvt Ltd

21-100 employees

Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.